Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 3/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.31 |
| ▸ | FEN1 | P39748 | 2/20 | 0.31 |
| ▸ | PDE2A | O00408 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11939218 | 0.96 | FPR2 (0.35) | FPR2PTGS1PTGS2ALOX5APFEN1 | |
| SCHEMBL12223288 | 0.91 | FPR2 (0.33) | FPR2ALOX5APFEN1 | |
| SCHEMBL11939167 | 0.90 | CNR2 (0.39) | ALOX5APFEN1 | |
| SCHEMBL11939058 | 0.90 | CNR2 (0.39) | ALOX5APFEN1 | |
| SCHEMBL12223936 | 0.90 | FPR2 (0.34) | FPR2PTGS1PTGS2ALOX5APFEN1 | |
| SCHEMBL12223286 | 0.89 | — | — | |
| SCHEMBL14922522 | 0.88 | FPR2 (0.37) | FPR2ALOX5APFEN1 | |
| SCHEMBL11939822 | 0.87 | NAAA (0.33) | FPR2ALOX5APFEN1 | |
| SCHEMBL11939128 | 0.87 | FPR2 (0.34) | FPR2ALOX5APFEN1 | |
| SCHEMBL12222857 | 0.87 | CNR2 (0.34) | FPR2ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110240919-A1 | FIVE-RING COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240919-A1 | FIVE-RING COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | NCAPD3, CCND3, ZKSCAN2 | FPR2 1970/4885PTGS1 3674/4885PTGS2 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.